Startup valuations are notoriously difficult
Founders often struggle to justify their numbers, investors question the assumptions, and both sides wrestle with inconsistent methods. Traditional financial models rarely work for early-stage ventures especially when value lies in intangible assets like IP, data, algorithms, regulatory pathways, or clinical evidence.
Without a clear valuation narrative, startups risk:
- Undervaluing themselves and giving away too much equity
- Overvaluing and losing investor credibility
- Failing to articulate the true strategic worth of their assets
- Stalling negotiations because the value drivers aren’t clearly understood or demonstrated
If you’ve ever wondered “What is my company really worth and how do I defend that number?” this masterclass is built for you.
Features and Benefits
Effective Learning
Video masterclass featuring real-world examples and frameworks for your project.
Industry Expert Led
Developed and taught by medical device investment experts and founders.
Instant Access Download
Get started today. Watch on-demand at your own pace.Masterclass Details
In this free masterclass, you’ll learn practical, founder-ready valuation techniques tailored for early-stage and growth-stage startups. You’ll discover: This is not academic theory. These are the tools used in real-world transactions: venture rounds, strategic partnerships, licensing deals, and M&A. Masterclass Agenda The unique challenges of early-stage valuation Why traditional corporate finance models often fail Understanding valuation as both a number and a strategic story Venture Capital Method Scorecard & Checklist methods Berkus Method Risk-factor summation DCF & comparables�“when they can still work How to combine methods for a credible valuation range Types of assets: patents, data, algorithms, regulatory approval pathways, clinical evidence, brand, know-how Cost, market, and income approaches for IP How acquirers and strategic partners value IP in real deals How to incorporate IP valuation into your overall enterprise value How to identify your value drivers How to quantify traction, scalability, defensibility, evidence, customer validation, and partnerships Translating value drivers into valuation uplift Building a valuation narrative investors believe Format: On-demand online video masterclass Duration: 1 - 1.5 h Dr. Sophie Laurenson, PhD / Executive MBA CEO and Founder, MedDev Central With 20 years of experience in the medical device industry�“as a startup founder, corporate scientist, and investor�“I’ve led and advised on valuations across the full product lifecycle, from early-stage concepts to due diligence and exit. My work spans financial modelling, IP strategy, corporate partnering and designing development and commercialisation plans specifically structured to maximise asset valuation. I’ve had the privilege of working with startups, corporates, and investors to navigate the complex dynamics of the MedTech landscape, aligning innovation with market needs and long-term value creation. I’m especially passionate about building pathways for medical devices that are not only clinically and commercially viable but also socially and environmentally sustainable.Agenda
Format
Instructor
Who it is for?
Format
Ready to Value Your Startup with Confidence?
Get access to the free masterclass and learn how to assess, articulate, and defend your valuation�“using proven methods trusted by investors and industry leaders.
Interested in learning more?
Check out our courses on business and asset valuation.
Early-Stage Statup Valuation: (for pre-revenue-generating startups)
Enterprise Valuation: (for later-stage or revenue-generating businesses)
Intellectual Property Valuation:
Comparables / Market-based Valuation:
